Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota.
- DOI
- 10.3389/fmicb.2022.908327
- Published
- 2022
- Container
- Frontiers in microbiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmicb.2022.908327,
title = {Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota.},
author = {Jin J and Wang J and Cheng R and Ren Y and Miao Z and Luo Y and Zhou Q and Xue Y and Shen X and He F and Tian H},
year = {2022},
journal = {Frontiers in microbiology},
doi = {10.3389/fmicb.2022.908327},
url = {https://doi.org/10.3389/fmicb.2022.908327}
}RIS
TY - JOUR TI - Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota. AU - Jin J AU - Wang J AU - Cheng R AU - Ren Y AU - Miao Z AU - Luo Y AU - Zhou Q AU - Xue Y AU - Shen X AU - He F AU - Tian H PY - 2022 JO - Frontiers in microbiology DO - 10.3389/fmicb.2022.908327 UR - https://doi.org/10.3389/fmicb.2022.908327 ER -
APA
J, J., J, W., R, C., Y, R., Z, M., Y, L., Q, Z., Y, X., X, S., F, H., & H, T. (2022). Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota.. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2022.908327
Source records
- pubmed · retrieved 2026-09-25T04:09:35.225Z